APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rivaroxaban

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

Selected research

Market Analysis & Forecast

Global Rivaroxaban Market Analysis and Forecast 2026-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchRivaroxaban Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Rivaroxaban Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Rivaroxaban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rivaroxaban Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Rivaroxaban Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.

This report presents an overview of global market for Rivaroxaban, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Rivaroxaban, also provides the sales of main regions and countries. Of the upcoming market potential for Rivaroxaban, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rivaroxaban sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rivaroxaban market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rivaroxaban sales, projected growth trends, production technology, application and end-user industry.

Rivaroxaban Segment by Company

Bayer

J&J

Rivaroxaban Segment by Type

2.5 mg

10 mg

15 mg

20 mg

Rivaroxaban Segment by Application

Acute Coronary Syndrome (ACS)

Venous Thromboembolism (VTE)

Rivaroxaban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rivaroxaban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rivaroxaban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rivaroxaban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rivaroxaban in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rivaroxaban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rivaroxaban sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rivaroxaban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5 mg Major Manufacturers Table 3. 10 mg Major Manufacturers Table 4. 15 mg Major Manufacturers Table 5. 20 mg Major Manufacturers Table 6. Global Rivaroxaban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Acute Coronary Syndrome (ACS) Major Manufacturers Table 8. Venous Thromboembolism (VTE) Major Manufacturers Table 9. Rivaroxaban Industry Trends Table 10. Rivaroxaban Industry Drivers Table 11. Rivaroxaban Industry Opportunities and Challenges Table 12. Rivaroxaban Industry Restraints Table 13. Global Rivaroxaban Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Rivaroxaban Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Rivaroxaban Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Rivaroxaban Revenue Market Share by Region (2021-2026) Table 17. Global Rivaroxaban Revenue Market Share by Region (2027-2032) Table 18. Global Rivaroxaban Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 19. Global Rivaroxaban Sales by Region (2021-2026) & (M Units) Table 20. Global Rivaroxaban Sales by Region (2027-2032) & (M Units) Table 21. Global Rivaroxaban Sales Market Share by Region (2021-2026) Table 22. Global Rivaroxaban Sales Market Share by Region (2027-2032) Table 23. Global Rivaroxaban Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Rivaroxaban Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Rivaroxaban Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rivaroxaban Sales Market Share by Manufacturers (2021-2026) Table 27. Global Rivaroxaban Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Rivaroxaban Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Rivaroxaban Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Rivaroxaban Manufacturers, Product Type & Application Table 31. Global Rivaroxaban Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Rivaroxaban by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Rivaroxaban Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Rivaroxaban Revenue Market Share by Type (2021-2026) Table 38. Global Rivaroxaban Revenue Market Share by Type (2027-2032) Table 39. Global Rivaroxaban Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 40. Global Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 41. Global Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 42. Global Rivaroxaban Sales Market Share by Type (2021-2026) Table 43. Global Rivaroxaban Sales Market Share by Type (2027-2032) Table 44. Global Rivaroxaban Price by Type (2021-2026) & (US$/Unit) Table 45. Global Rivaroxaban Price by Type (2027-2032) & (US$/Unit) Table 46. Global Rivaroxaban Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Rivaroxaban Revenue Market Share by Application (2021-2026) Table 50. Global Rivaroxaban Revenue Market Share by Application (2027-2032) Table 51. Global Rivaroxaban Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 52. Global Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 53. Global Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 54. Global Rivaroxaban Sales Market Share by Application (2021-2026) Table 55. Global Rivaroxaban Sales Market Share by Application (2027-2032) Table 56. Global Rivaroxaban Price by Application (2021-2026) & (US$/Unit) Table 57. Global Rivaroxaban Price by Application (2027-2032) & (US$/Unit) Table 58. Bayer Company Information Table 59. Bayer Business Overview Table 60. Bayer Rivaroxaban Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bayer Rivaroxaban Product Portfolio Table 62. Bayer Recent Development Table 63. J&J Company Information Table 64. J&J Business Overview Table 65. J&J Rivaroxaban Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. J&J Rivaroxaban Product Portfolio Table 67. J&J Recent Development Table 68. North America Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 71. North America Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 72. North America Rivaroxaban Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Rivaroxaban Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 77. North America Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 78. North America Rivaroxaban Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Rivaroxaban Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Rivaroxaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Rivaroxaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Rivaroxaban Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 84. North America Rivaroxaban Sales by Country (2021-2026) & (M Units) Table 85. North America Rivaroxaban Sales by Country (2027-2032) & (M Units) Table 86. North America Rivaroxaban Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Rivaroxaban Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 89. Canada Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 90. Mexico Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 91. Europe Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 94. Europe Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 95. Europe Rivaroxaban Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Rivaroxaban Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 100. Europe Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 101. Europe Rivaroxaban Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Rivaroxaban Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Rivaroxaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Rivaroxaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Rivaroxaban Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 107. Europe Rivaroxaban Sales by Country (2021-2026) & (M Units) Table 108. Europe Rivaroxaban Sales by Country (2027-2032) & (M Units) Table 109. Europe Rivaroxaban Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Rivaroxaban Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 112. France Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 113. U.K. Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 114. Italy Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 115. Russia Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 116. Spain Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 119. Sweden Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 120. Poland Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 121. China Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 122. China Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 123. China Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 124. China Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 125. China Rivaroxaban Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Rivaroxaban Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 128. China Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 129. China Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 130. China Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 131. China Rivaroxaban Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Rivaroxaban Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 136. Asia Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 137. Asia Rivaroxaban Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Rivaroxaban Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 142. Asia Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 143. Asia Rivaroxaban Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Rivaroxaban Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Rivaroxaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Rivaroxaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Rivaroxaban Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 149. Asia Rivaroxaban Sales by Country (2021-2026) & (M Units) Table 150. Asia Rivaroxaban Sales by Country (2027-2032) & (M Units) Table 151. Asia Rivaroxaban Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Rivaroxaban Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 154. South Korea Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 155. India Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 156. Australia Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Rivaroxaban Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Rivaroxaban Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Rivaroxaban Sales by Type (2021-2026) & (M Units) Table 162. SAMEA Rivaroxaban Sales by Type (2027-2032) & (M Units) Table 163. SAMEA Rivaroxaban Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Rivaroxaban Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Rivaroxaban Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Rivaroxaban Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Rivaroxaban Sales by Application (2021-2026) & (M Units) Table 168. SAMEA Rivaroxaban Sales by Application (2027-2032) & (M Units) Table 169. SAMEA Rivaroxaban Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Rivaroxaban Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Rivaroxaban Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Rivaroxaban Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Rivaroxaban Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 175. SAMEA Rivaroxaban Sales by Country (2021-2026) & (M Units) Table 176. SAMEA Rivaroxaban Sales by Country (2027-2032) & (M Units) Table 177. SAMEA Rivaroxaban Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Rivaroxaban Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 180. Argentina Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 181. Chile Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 182. Colombia Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 183. Peru Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 185. Israel Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 186. UAE Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 187. Turkey Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 188. Iran Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 189. Egypt Rivaroxaban Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Rivaroxaban Distributors List Table 193. Rivaroxaban Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Rivaroxaban Image Figure 2. Global Rivaroxaban Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rivaroxaban Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5 mg Image Figure 5. 10 mg Image Figure 6. 15 mg Image Figure 7. 20 mg Image Figure 8. Global Rivaroxaban Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Rivaroxaban Market Size Share 2021 VS 2025 VS 2032 Figure 10. Acute Coronary Syndrome (ACS) Image Figure 11. Venous Thromboembolism (VTE) Image Figure 12. Global Rivaroxaban Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rivaroxaban Revenue (2021-2032) & (US$ Million) Figure 14. Global Rivaroxaban Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Rivaroxaban Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Rivaroxaban Revenue Market Share by Region (2021-2032) Figure 17. Global Rivaroxaban Sales (2021-2032) & (M Units) Figure 18. Global Rivaroxaban Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 19. Global Rivaroxaban Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Rivaroxaban Sales YoY (2021-2032) & (M Units) Figure 21. Europe Rivaroxaban Sales YoY (2021-2032) & (M Units) Figure 22. China Rivaroxaban Sales YoY (2021-2032) & (M Units) Figure 23. Asia (Excluding China) Rivaroxaban Sales YoY (2021-2032) & (M Units) Figure 24. South America, Middle East and Africa Rivaroxaban Sales YoY (2021-2032) & (M Units) Figure 25. Global Rivaroxaban Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Rivaroxaban Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Rivaroxaban Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Rivaroxaban Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Rivaroxaban Revenue Market Share by Type (2021-2032) Figure 31. Global Rivaroxaban Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 32. Global Rivaroxaban Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Rivaroxaban Sales Market Share by Type (2021-2032) Figure 34. Global Rivaroxaban Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Rivaroxaban Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Rivaroxaban Revenue Market Share by Application (2021-2032) Figure 37. Global Rivaroxaban Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 38. Global Rivaroxaban Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Rivaroxaban Sales Market Share by Application (2021-2032) Figure 40. North America Rivaroxaban Revenue Share by Type (2021-2032) Figure 41. North America Rivaroxaban Sales Share by Type (2021-2032) Figure 42. North America Rivaroxaban Revenue Share by Application (2021-2032) Figure 43. North America Rivaroxaban Sales Share by Application (2021-2032) Figure 44. North America Rivaroxaban Revenue Share by Country (2021-2032) Figure 45. North America Rivaroxaban Sales Share by Country (2021-2032) Figure 46. Europe Rivaroxaban Revenue Share by Type (2021-2032) Figure 47. Europe Rivaroxaban Sales Share by Type (2021-2032) Figure 48. Europe Rivaroxaban Revenue Share by Application (2021-2032) Figure 49. Europe Rivaroxaban Sales Share by Application (2021-2032) Figure 50. Europe Rivaroxaban Revenue Share by Country (2021-2032) Figure 51. Europe Rivaroxaban Sales Share by Country (2021-2032) Figure 52. China Rivaroxaban Revenue Share by Type (2021-2032) Figure 53. China Rivaroxaban Sales Share by Type (2021-2032) Figure 54. China Rivaroxaban Revenue Share by Application (2021-2032) Figure 55. China Rivaroxaban Sales Share by Application (2021-2032) Figure 56. Asia Rivaroxaban Revenue Share by Type (2021-2032) Figure 57. Asia Rivaroxaban Sales Share by Type (2021-2032) Figure 58. Asia Rivaroxaban Revenue Share by Application (2021-2032) Figure 59. Asia Rivaroxaban Sales Share by Application (2021-2032) Figure 60. Asia Rivaroxaban Revenue Share by Country (2021-2032) Figure 61. Asia Rivaroxaban Sales Share by Country (2021-2032) Figure 62. SAMEA Rivaroxaban Revenue Share by Type (2021-2032) Figure 63. SAMEA Rivaroxaban Sales Share by Type (2021-2032) Figure 64. SAMEA Rivaroxaban Revenue Share by Application (2021-2032) Figure 65. SAMEA Rivaroxaban Sales Share by Application (2021-2032) Figure 66. SAMEA Rivaroxaban Revenue Share by Country (2021-2032) Figure 67. SAMEA Rivaroxaban Sales Share by Country (2021-2032) Figure 68. Rivaroxaban Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Rivaroxaban Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5 mg
  • 10 mg
  • 15 mg
  • 20 mg
Applications
  • Acute Coronary Syndrome (ACS)
  • Venous Thromboembolism (VTE)
Companies covered
  • Bayer
  • J&J

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rivaroxaban Market by Type
  3. 1.2.1 Global Rivaroxaban Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5 mg
  5. 1.2.3 10 mg
  6. 1.2.4 15 mg
  7. 1.2.5 20 mg
  8. 1.3 Rivaroxaban Market by Application
  9. 1.3.1 Global Rivaroxaban Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Acute Coronary Syndrome (ACS)
  11. 1.3.3 Venous Thromboembolism (VTE)
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rivaroxaban Market Dynamics
  1. 2.1 Rivaroxaban Industry Trends
  2. 2.2 Rivaroxaban Industry Drivers
  3. 2.3 Rivaroxaban Industry Opportunities and Challenges
  4. 2.4 Rivaroxaban Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rivaroxaban Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rivaroxaban Revenue by Region
  3. 3.2.1 Global Rivaroxaban Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rivaroxaban Revenue by Region (2021-2026)
  5. 3.2.3 Global Rivaroxaban Revenue by Region (2027-2032)
  6. 3.2.4 Global Rivaroxaban Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rivaroxaban Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rivaroxaban Sales by Region
  9. 3.4.1 Global Rivaroxaban Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rivaroxaban Sales by Region (2021-2026)
  11. 3.4.3 Global Rivaroxaban Sales by Region (2027-2032)
  12. 3.4.4 Global Rivaroxaban Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rivaroxaban Revenue by Manufacturers
  2. 4.1.1 Global Rivaroxaban Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rivaroxaban Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rivaroxaban Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rivaroxaban Sales by Manufacturers
  6. 4.2.1 Global Rivaroxaban Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rivaroxaban Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rivaroxaban Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rivaroxaban Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rivaroxaban Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rivaroxaban Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rivaroxaban Manufacturers, Product Type & Application
  13. 4.7 Global Rivaroxaban Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rivaroxaban Market CR5 and HHI
  16. 4.8.2 2025 Rivaroxaban Tier 1, Tier 2, and Tier 3
5 Rivaroxaban Market by Type
  1. 5.1 Global Rivaroxaban Revenue by Type
  2. 5.1.1 Global Rivaroxaban Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rivaroxaban Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rivaroxaban Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rivaroxaban Sales by Type
  6. 5.2.1 Global Rivaroxaban Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rivaroxaban Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Rivaroxaban Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rivaroxaban Price by Type
6 Rivaroxaban Market by Application
  1. 6.1 Global Rivaroxaban Revenue by Application
  2. 6.1.1 Global Rivaroxaban Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rivaroxaban Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rivaroxaban Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rivaroxaban Sales by Application
  6. 6.2.1 Global Rivaroxaban Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rivaroxaban Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Rivaroxaban Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rivaroxaban Price by Application
7 Company Profiles
  1. 7.1 Bayer
  2. 7.1.1 Bayer Company Information
  3. 7.1.2 Bayer Business Overview
  4. 7.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bayer Rivaroxaban Product Portfolio
  6. 7.1.5 Bayer Recent Developments
  7. 7.2 J&J
  8. 7.2.1 J&J Company Information
  9. 7.2.2 J&J Business Overview
  10. 7.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 J&J Rivaroxaban Product Portfolio
  12. 7.2.5 J&J Recent Developments
8 North America
  1. 8.1 North America Rivaroxaban Market Size by Type
  2. 8.1.1 North America Rivaroxaban Revenue by Type (2021-2032)
  3. 8.1.2 North America Rivaroxaban Sales by Type (2021-2032)
  4. 8.1.3 North America Rivaroxaban Price by Type (2021-2032)
  5. 8.2 North America Rivaroxaban Market Size by Application
  6. 8.2.1 North America Rivaroxaban Revenue by Application (2021-2032)
  7. 8.2.2 North America Rivaroxaban Sales by Application (2021-2032)
  8. 8.2.3 North America Rivaroxaban Price by Application (2021-2032)
  9. 8.3 North America Rivaroxaban Market Size by Country
  10. 8.3.1 North America Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rivaroxaban Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rivaroxaban Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rivaroxaban Market Size by Type
  2. 9.1.1 Europe Rivaroxaban Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rivaroxaban Sales by Type (2021-2032)
  4. 9.1.3 Europe Rivaroxaban Price by Type (2021-2032)
  5. 9.2 Europe Rivaroxaban Market Size by Application
  6. 9.2.1 Europe Rivaroxaban Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rivaroxaban Sales by Application (2021-2032)
  8. 9.2.3 Europe Rivaroxaban Price by Application (2021-2032)
  9. 9.3 Europe Rivaroxaban Market Size by Country
  10. 9.3.1 Europe Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rivaroxaban Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rivaroxaban Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rivaroxaban Market Size by Type
  2. 10.1.1 China Rivaroxaban Revenue by Type (2021-2032)
  3. 10.1.2 China Rivaroxaban Sales by Type (2021-2032)
  4. 10.1.3 China Rivaroxaban Price by Type (2021-2032)
  5. 10.2 China Rivaroxaban Market Size by Application
  6. 10.2.1 China Rivaroxaban Revenue by Application (2021-2032)
  7. 10.2.2 China Rivaroxaban Sales by Application (2021-2032)
  8. 10.2.3 China Rivaroxaban Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rivaroxaban Market Size by Type
  2. 11.1.1 Asia Rivaroxaban Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rivaroxaban Sales by Type (2021-2032)
  4. 11.1.3 Asia Rivaroxaban Price by Type (2021-2032)
  5. 11.2 Asia Rivaroxaban Market Size by Application
  6. 11.2.1 Asia Rivaroxaban Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rivaroxaban Sales by Application (2021-2032)
  8. 11.2.3 Asia Rivaroxaban Price by Application (2021-2032)
  9. 11.3 Asia Rivaroxaban Market Size by Country
  10. 11.3.1 Asia Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rivaroxaban Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rivaroxaban Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rivaroxaban Market Size by Type
  2. 12.1.1 SAMEA Rivaroxaban Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rivaroxaban Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rivaroxaban Price by Type (2021-2032)
  5. 12.2 SAMEA Rivaroxaban Market Size by Application
  6. 12.2.1 SAMEA Rivaroxaban Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rivaroxaban Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rivaroxaban Price by Application (2021-2032)
  9. 12.3 SAMEA Rivaroxaban Market Size by Country
  10. 12.3.1 SAMEA Rivaroxaban Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rivaroxaban Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rivaroxaban Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rivaroxaban Value Chain Analysis
  2. 13.1.1 Rivaroxaban Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rivaroxaban Production Mode & Process
  6. 13.2 Rivaroxaban Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rivaroxaban Distributors
  9. 13.2.3 Rivaroxaban Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst